Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with RAS inhibitors

INTRODUCTION: Renin-angiotensin system (RAS) inhibitors have been increasingly prescribed due to their beneficial effects on end-organ protection. Iatrogenic hyperkalemia is a well-known life-threatening complication of RAS inhibitor use in chronic kidney disease (CKD) patients. We hypothesized that...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yuki, Yamamoto, Hiroyuki, Nakajima, Hideki, Takahashi, Osamu, Komatsu, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587314/
https://www.ncbi.nlm.nih.gov/pubmed/28877239
http://dx.doi.org/10.1371/journal.pone.0184402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587314/
https://www.ncbi.nlm.nih.gov/pubmed/28877239
http://dx.doi.org/10.1371/journal.pone.0184402

Ejemplares similares